NVDA Directional Report

Analysis based on market close April 2, 2026

Outlook

Neutral-to-bullish with a strong pinning force toward $175-$180. Confidence: 7/10. Massive positive GEX ($250.5M) and net bullish premium ($157.7M) create a powerful mean-reverting regime, but spot is slightly above the dominant max pain cluster, which may cap immediate upside.

Confidence:

7 / 10

Base 7.0 stands. +$250.5M GEX is a strong pinning force; +$157.7M net premium confirms bullish institutional conviction. No overrides.

Supports: GEX +$250.5M (pinning), Net Premium +$157.7M (bullish), Rising MP trend ($90 → $185)
Conflicts: Spot ($177.39) is above the $175 MP cluster; P/C ratios near 0.9 show mixed flow.

📌GEX pin concentrated near $175-$180 across multiple expirations.

📈Max pain ladder shows a clear upward trend over time, supporting a structural bullish drift.

Regime Classification

Vol Regime

Normal

IV 44.3% is elevated but normal for NVDA, offering rich premium for sellers if the pin holds.

Gamma Regime

Pinning

GEX +$250.5M is strongly positive, creating a mean-reverting force that pins spot near $175-$180.

Flow Regime

Mixed

Net premium +$157.7M is bullish, but P/C ratios near 0.9 show mixed activity, suggesting some hedging.

Spot vs Max Pain

Above

Spot is above the dominant $175 max pain cluster, suggesting gravity may pull it back toward the pin.

Thesis duration: Multi-week — Max pain ladder shows a persistent $175-$180 pin across April and May expirations, and GEX sign is stable positive. The bullish flow regime is consistent across timeframes.

Price Range Forecast

Next 1 week

$172.42$182.35

GEX pin dominates; a break above $182.35 (1w EM high) or below $172.42 (1w EM low) invalidates the tight range.

Next 2 weeks

$168.31$186.46

Flow and rising MP trend support a drift toward $185-$186; failure below $168.31 (2w EM low) invalidates.

Key Levels

Max pain pins: $90 (2026-03-23); $175 (2026-03-25); $175 (2026-03-27)

EM guardrails: 1w $172.42/$182.35

Support: $140.00 · $75.00

Resistance: $200.00 · $200.00 · $200.00

Gamma flip: ~$140.00 — Approx — based on put OI concentration of 91,943

Structural: Massive call OI wall at $200 caps major upside; put floor at $140/$75 provides distant but significant support.

Dealer Positioning (GEX/DEX)

GEX: $+250.5M

DEX: +369.2M shares

Gamma flip: ~$140 (Approx — based on put OI concentration of 91,943)

NTM gamma: Dealers are net long gamma, hedging by selling into rallies and buying into dips, reinforcing the $175-$180 pin. A move below ~$140 flips them short gamma, accelerating selling.

IV Analysis

IV vs VIX: N/A (VIX not provided), but IV 44.3% is elevated historically, favoring premium sellers if the pin holds.

Term structure: Steeply upward sloping from 22.2% (4/06) to ~44% (6mo+). No major event kinks visible; earnings (~5/20) not yet priced.

Skew: 4/06 ($177.5C IV 22.3%) vs 4/08 ($177.5C IV ~27.6%) offers a ~5 vol-pt differential for a reverse calendar (sell far, buy near).

Flow Analysis

Net premium: +$157.7M bullish; P/C vol 0.91, P/C OI 0.90

Directional prints: $177.5C 4/06 vol 31,545 vs OI 4,194 (7.5x) — likely bought calls for near-term upside. $150P 5/01 vol 69,092 vs OI 2,885 (23.9x) at 43.4% IV — could be protective put buying or selling; selling is more consistent with the bullish flow regime.

Unusual: Massive premium flow at $177.50, $180, and $175 calls (net +$20M+ each) confirms institutional call positioning.

Risks & Catalysts

!Gamma flip at ~$140; a break below accelerates downside.

!Elevated IV (44.3%) implies high volatility risk for short premium.

!$200 call OI wall represents a major supply zone if rally extends.

!Earnings expected ~5/20 will repricing vol term structure.

Strategy Viability

Strategy	Edge	Best Setup	Primary Risk
Iron condor	Moderate	Sell $172.5/$170P x $182.5/$185C, 4/17 expiry.	VIX spike or pin break; GEX positive supports but IV >40% is headwind.
CSP / put spread	Moderate-Strong	Sell $175/$172.5 put spread, 4/17 expiry.	Spot breaks below $172.42 1w EM low.
Covered call	Moderate-Strong	Own stock, sell $180C 4/17 expiry.	Capped upside if stock rallies past $180.
Cash-secured put	Moderate-Strong	Sell $175P 4/17 expiry.	Assignment at $175.
Long calls	Moderate-Weak	Buy $180C 4/17 expiry.	Pinning and high IV crush; better for breakout >$182.35.
Long puts / bear put spread	Weak	Avoid — contradicts bullish flow and pinning regime.	GEX pin and bullish flow create strong headwind.
Calendar/diagonal	Moderate	Sell $177.5C 4/08, buy $177.5C 4/06 (reverse calendar).	Pin holds exactly at $177.5; theta decay on short leg.
PMCC / LEAPS diagonal	Moderate-Strong	Buy $160C Jan 2027, sell $180C 4/17 against it.	Long-dated IV rich; short call pin risk.

Top Plays

Put Spread at Pin

Sell NVDA $175/$172.5 Put Spread, 15 DTE (4/17 expiry).

Collects premium while positioning just below the strong $175 pin, aligning with the mean-reverting GEX regime. Defined risk if pin breaks.

Credit: $0.85-$1.05

Max loss: $1.65

BE: $174.15

Mgmt: Close at 60-70% max profit; exit on close below $172.42 (1w EM low).

Traders seeking defined-risk premium collection in a pinned, high-IV environment.

Covered Call Over Pin

Own NVDA shares, sell the $180 Call, 15 DTE (4/17 expiry).

Generates income against existing stock while setting a sell target at the upper EM bound ($182.35). The pinning regime makes a slow grind upward likely, favoring call overwriting.

Credit: $6.00-$7.50

Max loss: Unlimited below stock price

BE: Stock price minus credit

Mgmt: Close call at 50% profit if spot drops sharply. Consider rolling up if spot approaches $182.

Existing shareholders looking to enhance yield in a range-bound, high-IV environment.

PMCC for Leveraged Income

Buy NVDA $160 Call (Jan 2027), sell $180 Call (4/17) against it.

The 300+ DTE long leg captures the structural bullish flow and rising max pain trend over months, while the short leg harvests rich weekly premium from the pin. The extra time provides leverage and mitigates the risk of a temporary pin break, improving risk/reward versus a naked long call.

Debit: $20.00-$23.00

Max loss: Cost of long call

BE: $183.00

Mgmt: Manage short leg weekly; roll long leg only if thesis breaks (close below $160).

Traders with larger capital seeking leveraged, theta-positive exposure to NVDA's long-term uptrend with monthly income.

Watchlist Triggers

Entry Triggers

IFSpot rallies to tag $179.26 (prior 1w EM high) and stalls. → Sell $180/$182.5 call credit spread, 4/17 expiry.

IFSpot drops to $172.5 and 30-min RSI < 30. → Sell $172.5/$170 put spread, 4/17 expiry.

Exit Triggers

EXITSpot closes above $185 (breaking 2w EM high). → Exit all short call positions (spreads, covered calls).

EXITSpot closes below $168.31 (2w EM low). → Exit all short put positions and reconsider bullish thesis.

Tactical Summary

Primary thesis: NVDA is pinned to $175-$180 by strong positive GEX, with a bullish drift supported by institutional flow and a rising max pain trend. Favor selling premium at the edges of the expected move ($172.42-$182.35). Invalidation is a close below $168.31. Top plays: put spread at $175 for premium collectors, covered calls at $180 for shareholders, and a PMCC for leveraged directional income.

Read the Directional analysis for NVDA. This AI-generated report covers regime classification, key price levels, strategy recommendations, and actionable trade ideas drawn from end-of-day options data including gamma exposure, delta exposure, and implied volatility.